Hantz Financial Services, Inc. Sarepta Therapeutics, Inc. Transaction History
Hantz Financial Services, Inc.
- $6.6 Billion
- Q3 2025
A detailed history of Hantz Financial Services, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 621 shares of SRPT stock, worth $11,681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
621
Previous 319
94.67%
Holding current value
$11,681
Previous $5,000
140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
418Shares Held
85.3MCall Options Held
5.27MPut Options Held
5.96M-
Vanguard Group Inc Valley Forge, PA11.8MShares$222 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA5.3MShares$99.8 Million0.0% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.65MShares$49.8 Million0.07% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...